158 related articles for article (PubMed ID: 33171158)
1. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
Tanner NT; Springmeyer SC; Porter A; Jett JR; Mazzone P; Vachani A; Silvestri GA
Chest; 2021 Mar; 159(3):1283-1287. PubMed ID: 33171158
[No Abstract] [Full Text] [Related]
2. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary nodules as incidental findings.
Simon M; Zukotynski K; Naeger DM
CMAJ; 2018 Feb; 190(6):E167. PubMed ID: 29440337
[No Abstract] [Full Text] [Related]
4. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
[TBL] [Abstract][Full Text] [Related]
5. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
7. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
8. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography and the secrets of lung nodules.
Mayo JR; Lam S
Can Assoc Radiol J; 2015 Feb; 66(1):2-4. PubMed ID: 25623006
[No Abstract] [Full Text] [Related]
10. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
11. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification for lung nodules: Size isn't everything.
Eguchi T; Adusumilli PS
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1557-1562. PubMed ID: 28314535
[No Abstract] [Full Text] [Related]
13. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.
Maldonado F; Boland JM; Raghunath S; Aubry MC; Bartholmai BJ; Deandrade M; Hartman TE; Karwoski RA; Rajagopalan S; Sykes AM; Yang P; Yi ES; Robb RA; Peikert T
J Thorac Oncol; 2013 Apr; 8(4):452-60. PubMed ID: 23486265
[TBL] [Abstract][Full Text] [Related]
14. Vessel suppressed chest Computed Tomography for semi-automated volumetric measurements of solid pulmonary nodules.
Milanese G; Eberhard M; Martini K; Vittoria De Martini I; Frauenfelder T
Eur J Radiol; 2018 Apr; 101():97-102. PubMed ID: 29571809
[TBL] [Abstract][Full Text] [Related]
15. Probability of cancer in pulmonary nodules detected on first screening CT.
McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and work-up of small to intermediate-sized pulmonary nodules in a Chinese dedicated cancer hospital.
Cui X; Han D; Heuvelmans MA; Du Y; Zhao Y; Zhang L; Groen HJM; de Bock GH; Dorrius MD; Oudkerk M; Vliegenthart R; Ye Z
Cancer Biol Med; 2020 Feb; 17(1):199-207. PubMed ID: 32296586
[No Abstract] [Full Text] [Related]
17. [Advances and Clinical Application of Malignant Probability Prediction Models for
Solitary Pulmonary Nodule].
Wang Z; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):660-667. PubMed ID: 34455736
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a "coffee-break".
Talwar A; Willaime JMY; Pickup LC; Enescu M; Boukerroui D; Hickes W; Rahman NM; Gooding MJ; Kadir T; Gleeson FV
Eur J Radiol; 2018 Apr; 101():82-86. PubMed ID: 29571806
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region.
Henz Concatto N; Watte G; Marchiori E; Irion K; Felicetti JC; Camargo JJ; Hochhegger B
Eur Radiol; 2016 Sep; 26(9):2915-20. PubMed ID: 26638164
[TBL] [Abstract][Full Text] [Related]
20. Benign pathologies results from lung nodule percutaneous biopsies: How to differentiate true and false benign?
Li L; Xu XL; Feng K; Liu XQ; Yang J
J Cancer Res Ther; 2021 Jul; 17(3):658-663. PubMed ID: 34269296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
